Registry for patients with adrenocortical carcinoma in Germany

Deutsches Nebennieren-Karzinom-Register - German Adrenocortical Carcinoma Registry

Observational University of Wuerzburg · NCT00453674

This study is collecting information from patients with adrenocortical cancer in Germany to help improve their treatment and care in the future.

Quick facts

Study typeObservational
Enrollment1000 (estimated)
SexAll
SponsorUniversity of Wuerzburg Academic / other
Locations1 site (Würzburg)
Trial IDNCT00453674 on ClinicalTrials.gov

What this trial studies

The German Adrenocortical Carcinoma Registry aims to enhance the care of patients diagnosed with adrenocortical cancer by collecting extensive data on treatment outcomes and prognoses. By registering as many patients as possible, the study facilitates the planning of future prospective studies and improves recruitment for these studies. The registry also aims to collaborate with international networks to systematically enhance treatment strategies for this rare cancer.

Who should consider this trial

Good fit: Ideal candidates for this registry are individuals with a histologically confirmed diagnosis of adrenocortical carcinoma.

Not a fit: Patients without a confirmed diagnosis of adrenocortical carcinoma will not benefit from this registry.

Why it matters

Potential benefit: If successful, this registry could lead to improved treatment protocols and outcomes for patients with adrenocortical carcinoma.

How similar studies have performed: Other registries and collaborative studies in oncology have shown success in improving patient outcomes through data collection and analysis.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Histologically confirmed diagnosis of adrenocortical carcinoma

Where this trial is running

Würzburg

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Adrenocortical CarcinomaAdrenal cancerTreatmentSurgeryMitotane
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.